GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zfx
|
ENSMUSG00000079509.4 | zinc finger protein X-linked |
Zfp711
|
ENSMUSG00000025529.8 | zinc finger protein 711 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Zfx | mm10_v2_chrX_-_94123087_94123159 | -0.50 | 1.9e-03 | Click! |
Zfp711 | mm10_v2_chrX_+_112615301_112615301 | -0.49 | 2.4e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_-_88503952 | 8.40 |
ENSMUST00000020253.8
|
Chpt1
|
choline phosphotransferase 1 |
chr3_-_18243289 | 7.82 |
ENSMUST00000035625.6
|
Cyp7b1
|
cytochrome P450, family 7, subfamily b, polypeptide 1 |
chr4_+_43631935 | 7.38 |
ENSMUST00000030191.8
|
Npr2
|
natriuretic peptide receptor 2 |
chr4_-_61674094 | 6.89 |
ENSMUST00000098040.3
|
Mup18
|
major urinary protein 18 |
chr4_-_60222580 | 6.35 |
ENSMUST00000095058.4
ENSMUST00000163931.1 |
Mup8
|
major urinary protein 8 |
chr10_-_88503912 | 6.16 |
ENSMUST00000117579.1
ENSMUST00000073783.5 |
Chpt1
|
choline phosphotransferase 1 |
chr4_+_63344548 | 5.96 |
ENSMUST00000030044.2
|
Orm1
|
orosomucoid 1 |
chr4_-_60499332 | 5.74 |
ENSMUST00000135953.1
|
Mup1
|
major urinary protein 1 |
chr7_-_97417730 | 5.53 |
ENSMUST00000043077.7
|
Thrsp
|
thyroid hormone responsive |
chr12_+_108334341 | 5.45 |
ENSMUST00000021684.4
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr11_-_120824098 | 5.45 |
ENSMUST00000055655.7
|
Fasn
|
fatty acid synthase |
chr15_+_76268076 | 5.11 |
ENSMUST00000074173.3
|
Spatc1
|
spermatogenesis and centriole associated 1 |
chr4_-_60421933 | 4.90 |
ENSMUST00000107506.2
ENSMUST00000122381.1 ENSMUST00000118759.1 ENSMUST00000122177.1 |
Mup9
|
major urinary protein 9 |
chr8_+_85492568 | 4.87 |
ENSMUST00000034136.5
|
Gpt2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2 |
chr9_-_98955302 | 4.73 |
ENSMUST00000181706.1
|
Foxl2os
|
forkhead box L2 opposite strand transcript |
chr1_-_192834719 | 4.66 |
ENSMUST00000057543.2
|
A730013G03Rik
|
RIKEN cDNA A730013G03 gene |
chr16_+_44173271 | 4.66 |
ENSMUST00000088356.4
ENSMUST00000169582.1 |
Gm608
|
predicted gene 608 |
chr2_-_181043540 | 4.62 |
ENSMUST00000124400.1
|
Chrna4
|
cholinergic receptor, nicotinic, alpha polypeptide 4 |
chr1_+_74332596 | 4.61 |
ENSMUST00000087225.5
|
Pnkd
|
paroxysmal nonkinesiogenic dyskinesia |
chr4_-_60582152 | 4.57 |
ENSMUST00000098047.2
|
Mup10
|
major urinary protein 10 |
chr9_-_64341145 | 4.17 |
ENSMUST00000120760.1
ENSMUST00000168844.2 |
Dis3l
|
DIS3 mitotic control homolog (S. cerevisiae)-like |
chr10_-_88504073 | 4.14 |
ENSMUST00000117440.1
|
Chpt1
|
choline phosphotransferase 1 |
chr7_+_87246649 | 3.95 |
ENSMUST00000068829.5
ENSMUST00000032781.7 |
Nox4
|
NADPH oxidase 4 |
chr10_+_88459569 | 3.81 |
ENSMUST00000020252.3
ENSMUST00000125612.1 |
Sycp3
|
synaptonemal complex protein 3 |
chr7_-_141276729 | 3.80 |
ENSMUST00000167263.1
ENSMUST00000080654.5 |
Cdhr5
|
cadherin-related family member 5 |
chr4_+_43632185 | 3.73 |
ENSMUST00000107874.2
|
Npr2
|
natriuretic peptide receptor 2 |
chr1_+_74713551 | 3.67 |
ENSMUST00000027356.5
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1 |
chr11_-_74925658 | 3.65 |
ENSMUST00000138612.1
ENSMUST00000123855.1 ENSMUST00000128556.1 ENSMUST00000108448.1 ENSMUST00000108447.1 ENSMUST00000065211.2 |
Srr
|
serine racemase |
chr15_+_33083110 | 3.62 |
ENSMUST00000042167.9
|
Cpq
|
carboxypeptidase Q |
chr16_-_18089022 | 3.59 |
ENSMUST00000132241.1
ENSMUST00000139861.1 ENSMUST00000003620.5 |
Prodh
|
proline dehydrogenase |
chr11_+_60105079 | 3.56 |
ENSMUST00000132012.1
|
Rai1
|
retinoic acid induced 1 |
chr4_-_61303998 | 3.50 |
ENSMUST00000071005.8
ENSMUST00000075206.5 |
Mup14
|
major urinary protein 14 |
chr9_-_64341288 | 3.49 |
ENSMUST00000068367.7
|
Dis3l
|
DIS3 mitotic control homolog (S. cerevisiae)-like |
chr8_+_107150621 | 3.48 |
ENSMUST00000034400.3
|
Cyb5b
|
cytochrome b5 type B |
chr13_-_29984219 | 3.47 |
ENSMUST00000146092.1
|
E2f3
|
E2F transcription factor 3 |
chr11_-_74925925 | 3.46 |
ENSMUST00000121738.1
|
Srr
|
serine racemase |
chr14_+_37054818 | 3.41 |
ENSMUST00000120052.1
|
Lrit1
|
leucine-rich repeat, immunoglobulin-like and transmembrane domains 1 |
chr16_+_13903152 | 3.39 |
ENSMUST00000128757.1
|
Mpv17l
|
Mpv17 transgene, kidney disease mutant-like |
chr7_-_80401707 | 3.38 |
ENSMUST00000120753.1
|
Furin
|
furin (paired basic amino acid cleaving enzyme) |
chr2_-_102400863 | 3.33 |
ENSMUST00000102573.1
|
Trim44
|
tripartite motif-containing 44 |
chr1_-_180256294 | 3.33 |
ENSMUST00000111108.3
|
Psen2
|
presenilin 2 |
chr9_-_86695897 | 3.30 |
ENSMUST00000034989.8
|
Me1
|
malic enzyme 1, NADP(+)-dependent, cytosolic |
chrX_+_99821021 | 3.19 |
ENSMUST00000096363.2
|
Tmem28
|
transmembrane protein 28 |
chr4_+_60003438 | 3.17 |
ENSMUST00000107517.1
ENSMUST00000107520.1 |
Mup6
|
major urinary protein 6 |
chr17_-_24209377 | 3.16 |
ENSMUST00000024931.4
|
Ntn3
|
netrin 3 |
chr16_+_44173239 | 3.16 |
ENSMUST00000119746.1
|
Gm608
|
predicted gene 608 |
chr4_-_62087261 | 3.15 |
ENSMUST00000107488.3
ENSMUST00000107472.1 ENSMUST00000084531.4 |
Mup3
|
major urinary protein 3 |
chr1_+_78657874 | 3.13 |
ENSMUST00000134566.1
ENSMUST00000142704.1 ENSMUST00000053760.5 |
Acsl3
Utp14b
|
acyl-CoA synthetase long-chain family member 3 UTP14, U3 small nucleolar ribonucleoprotein, homolog B (yeast) |
chr9_+_54863742 | 3.13 |
ENSMUST00000034843.7
|
Ireb2
|
iron responsive element binding protein 2 |
chr7_-_34655500 | 3.12 |
ENSMUST00000032709.1
|
Kctd15
|
potassium channel tetramerisation domain containing 15 |
chr2_-_73386396 | 3.12 |
ENSMUST00000112044.1
ENSMUST00000112043.1 ENSMUST00000076463.5 |
Gpr155
|
G protein-coupled receptor 155 |
chr4_-_59960659 | 3.11 |
ENSMUST00000075973.2
|
Mup4
|
major urinary protein 4 |
chrX_+_36598199 | 3.06 |
ENSMUST00000073339.6
|
Pgrmc1
|
progesterone receptor membrane component 1 |
chr5_+_65764073 | 3.03 |
ENSMUST00000138239.1
ENSMUST00000087264.3 |
N4bp2
|
NEDD4 binding protein 2 |
chr2_-_33371400 | 3.03 |
ENSMUST00000113164.1
ENSMUST00000091039.2 ENSMUST00000042615.6 |
Ralgps1
|
Ral GEF with PH domain and SH3 binding motif 1 |
chr4_-_148159838 | 3.02 |
ENSMUST00000151127.1
ENSMUST00000105705.2 |
Fbxo44
|
F-box protein 44 |
chr4_-_61519467 | 2.97 |
ENSMUST00000095051.5
ENSMUST00000107483.1 |
Mup16
|
major urinary protein 16 |
chr11_-_120784183 | 2.95 |
ENSMUST00000026156.7
|
Rfng
|
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr15_-_10470490 | 2.87 |
ENSMUST00000136591.1
|
Dnajc21
|
DnaJ (Hsp40) homolog, subfamily C, member 21 |
chr4_-_60070411 | 2.83 |
ENSMUST00000079697.3
ENSMUST00000125282.1 ENSMUST00000166098.1 |
Mup7
|
major urinary protein 7 |
chr11_-_50325599 | 2.83 |
ENSMUST00000179865.1
ENSMUST00000020637.8 |
Canx
|
calnexin |
chr3_+_63295815 | 2.81 |
ENSMUST00000029400.1
|
Mme
|
membrane metallo endopeptidase |
chr7_+_143052739 | 2.80 |
ENSMUST00000037941.9
|
Cd81
|
CD81 antigen |
chr4_+_83525540 | 2.76 |
ENSMUST00000053414.6
ENSMUST00000126429.1 |
Ccdc171
|
coiled-coil domain containing 171 |
chr19_+_46131888 | 2.76 |
ENSMUST00000043739.3
|
Elovl3
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 |
chr1_-_153900198 | 2.76 |
ENSMUST00000123490.1
|
5830403L16Rik
|
RIKEN cDNA 5830403L16 gene |
chr4_+_106316187 | 2.73 |
ENSMUST00000165709.1
ENSMUST00000106798.1 ENSMUST00000094933.4 |
Usp24
|
ubiquitin specific peptidase 24 |
chr4_-_62054112 | 2.73 |
ENSMUST00000074018.3
|
Mup20
|
major urinary protein 20 |
chr11_+_35769462 | 2.72 |
ENSMUST00000018990.7
|
Pank3
|
pantothenate kinase 3 |
chr6_+_47454320 | 2.71 |
ENSMUST00000031697.8
|
Cul1
|
cullin 1 |
chr10_-_83337440 | 2.70 |
ENSMUST00000126617.1
|
Slc41a2
|
solute carrier family 41, member 2 |
chr18_+_24205722 | 2.70 |
ENSMUST00000170243.1
|
Galnt1
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 |
chr18_+_38418946 | 2.69 |
ENSMUST00000025293.3
|
Ndfip1
|
Nedd4 family interacting protein 1 |
chr4_+_33209259 | 2.69 |
ENSMUST00000108159.1
|
Srsf12
|
serine/arginine-rich splicing factor 12 |
chr9_+_108854024 | 2.56 |
ENSMUST00000098376.3
|
Slc26a6
|
solute carrier family 26, member 6 |
chr13_-_9764943 | 2.53 |
ENSMUST00000110634.1
|
Zmynd11
|
zinc finger, MYND domain containing 11 |
chr13_-_9765137 | 2.50 |
ENSMUST00000062658.8
ENSMUST00000130151.1 ENSMUST00000110636.1 ENSMUST00000152725.1 |
Zmynd11
|
zinc finger, MYND domain containing 11 |
chr4_-_105109829 | 2.48 |
ENSMUST00000030243.7
|
Prkaa2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit |
chr12_-_108179210 | 2.48 |
ENSMUST00000125916.2
ENSMUST00000109879.1 |
Setd3
|
SET domain containing 3 |
chr8_+_13159135 | 2.47 |
ENSMUST00000033824.6
|
Lamp1
|
lysosomal-associated membrane protein 1 |
chr11_+_94327984 | 2.46 |
ENSMUST00000107818.2
ENSMUST00000051221.6 |
Ankrd40
|
ankyrin repeat domain 40 |
chr11_+_94328242 | 2.45 |
ENSMUST00000021227.5
|
Ankrd40
|
ankyrin repeat domain 40 |
chr6_+_71494003 | 2.45 |
ENSMUST00000114179.2
|
Rnf103
|
ring finger protein 103 |
chr13_-_66933014 | 2.45 |
ENSMUST00000173773.1
|
Mterfd1
|
MTERF domain containing 1 |
chr5_-_53213447 | 2.45 |
ENSMUST00000031090.6
|
Sel1l3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr11_-_97280470 | 2.44 |
ENSMUST00000167806.1
ENSMUST00000172108.1 |
Npepps
|
aminopeptidase puromycin sensitive |
chr15_+_59315088 | 2.44 |
ENSMUST00000100640.4
|
Sqle
|
squalene epoxidase |
chr2_-_25469742 | 2.44 |
ENSMUST00000114259.2
ENSMUST00000015234.6 |
Ptgds
|
prostaglandin D2 synthase (brain) |
chr6_+_145746739 | 2.43 |
ENSMUST00000111704.1
|
Rassf8
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
chr7_-_81454751 | 2.43 |
ENSMUST00000098331.3
ENSMUST00000178892.1 |
Cpeb1
|
cytoplasmic polyadenylation element binding protein 1 |
chr11_-_61855026 | 2.43 |
ENSMUST00000004920.3
|
Ulk2
|
unc-51 like kinase 2 |
chr18_-_61036189 | 2.42 |
ENSMUST00000025521.8
|
Cdx1
|
caudal type homeobox 1 |
chr7_-_114562945 | 2.41 |
ENSMUST00000119712.1
ENSMUST00000032908.8 |
Cyp2r1
|
cytochrome P450, family 2, subfamily r, polypeptide 1 |
chr7_-_43489967 | 2.40 |
ENSMUST00000107974.1
|
Iglon5
|
IgLON family member 5 |
chr11_-_5950018 | 2.40 |
ENSMUST00000102920.3
|
Gck
|
glucokinase |
chr18_-_88894203 | 2.39 |
ENSMUST00000123826.1
|
Socs6
|
suppressor of cytokine signaling 6 |
chr4_+_116877376 | 2.38 |
ENSMUST00000044823.3
|
Zswim5
|
zinc finger SWIM-type containing 5 |
chr7_-_127026479 | 2.37 |
ENSMUST00000032916.4
|
Maz
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chrX_-_74023745 | 2.37 |
ENSMUST00000114353.3
ENSMUST00000101458.2 |
Irak1
|
interleukin-1 receptor-associated kinase 1 |
chr9_+_123529843 | 2.37 |
ENSMUST00000026270.7
|
Sacm1l
|
SAC1 (suppressor of actin mutations 1, homolog)-like (S. cerevisiae) |
chr3_-_121815212 | 2.34 |
ENSMUST00000029770.5
|
Abcd3
|
ATP-binding cassette, sub-family D (ALD), member 3 |
chr11_+_103101682 | 2.31 |
ENSMUST00000107040.3
ENSMUST00000140372.1 ENSMUST00000024492.8 ENSMUST00000134884.1 |
Acbd4
|
acyl-Coenzyme A binding domain containing 4 |
chr15_-_78468620 | 2.31 |
ENSMUST00000017086.3
|
Tmprss6
|
transmembrane serine protease 6 |
chr15_+_76696725 | 2.30 |
ENSMUST00000023203.4
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr17_-_31636631 | 2.30 |
ENSMUST00000135425.1
ENSMUST00000151718.1 ENSMUST00000155814.1 |
Cbs
|
cystathionine beta-synthase |
chr14_+_30715599 | 2.30 |
ENSMUST00000054230.4
|
Sfmbt1
|
Scm-like with four mbt domains 1 |
chr12_+_78226627 | 2.30 |
ENSMUST00000110388.2
ENSMUST00000052472.4 |
Gphn
|
gephyrin |
chr8_-_45358737 | 2.29 |
ENSMUST00000155230.1
ENSMUST00000135912.1 |
Fam149a
|
family with sequence similarity 149, member A |
chr9_+_55326913 | 2.26 |
ENSMUST00000085754.3
ENSMUST00000034862.4 |
AI118078
|
expressed sequence AI118078 |
chr5_-_113993740 | 2.26 |
ENSMUST00000112298.3
|
Ssh1
|
slingshot homolog 1 (Drosophila) |
chr2_+_31470207 | 2.26 |
ENSMUST00000102840.4
|
Ass1
|
argininosuccinate synthetase 1 |
chr11_+_58009064 | 2.26 |
ENSMUST00000071487.6
ENSMUST00000178636.1 |
Larp1
|
La ribonucleoprotein domain family, member 1 |
chr1_-_136260873 | 2.25 |
ENSMUST00000086395.5
|
Gpr25
|
G protein-coupled receptor 25 |
chr3_+_66985700 | 2.24 |
ENSMUST00000046542.6
ENSMUST00000162693.1 |
Rsrc1
|
arginine/serine-rich coiled-coil 1 |
chr3_+_57736056 | 2.23 |
ENSMUST00000041826.9
|
Rnf13
|
ring finger protein 13 |
chr19_-_8131982 | 2.23 |
ENSMUST00000065651.4
|
Slc22a28
|
solute carrier family 22, member 28 |
chr18_+_24709436 | 2.23 |
ENSMUST00000037097.7
|
Fhod3
|
formin homology 2 domain containing 3 |
chr4_+_41135743 | 2.22 |
ENSMUST00000040008.3
|
Ube2r2
|
ubiquitin-conjugating enzyme E2R 2 |
chr18_+_3383223 | 2.21 |
ENSMUST00000162301.1
ENSMUST00000161317.1 |
Cul2
|
cullin 2 |
chr14_+_74732384 | 2.20 |
ENSMUST00000176957.1
|
Esd
|
esterase D/formylglutathione hydrolase |
chr4_-_148160031 | 2.20 |
ENSMUST00000057907.3
|
Fbxo44
|
F-box protein 44 |
chr11_+_52232009 | 2.19 |
ENSMUST00000037324.5
ENSMUST00000166537.1 |
Skp1a
|
S-phase kinase-associated protein 1A |
chr18_-_63692341 | 2.19 |
ENSMUST00000025476.2
|
Txnl1
|
thioredoxin-like 1 |
chr11_+_57801575 | 2.19 |
ENSMUST00000020826.5
|
Sap30l
|
SAP30-like |
chr6_+_56714891 | 2.17 |
ENSMUST00000031805.8
|
Avl9
|
AVL9 homolog (S. cerevisiase) |
chr4_-_61835185 | 2.17 |
ENSMUST00000082287.2
|
Mup5
|
major urinary protein 5 |
chr14_-_29721835 | 2.16 |
ENSMUST00000022567.7
|
Cacna2d3
|
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
chrX_+_13071470 | 2.16 |
ENSMUST00000169594.2
|
Usp9x
|
ubiquitin specific peptidase 9, X chromosome |
chr5_+_72914554 | 2.14 |
ENSMUST00000143829.1
|
Slain2
|
SLAIN motif family, member 2 |
chr11_+_52232183 | 2.13 |
ENSMUST00000109072.1
|
Skp1a
|
S-phase kinase-associated protein 1A |
chr11_-_70700105 | 2.13 |
ENSMUST00000108543.3
ENSMUST00000108542.1 ENSMUST00000108541.2 ENSMUST00000126114.2 ENSMUST00000073625.1 |
Inca1
|
inhibitor of CDK, cyclin A1 interacting protein 1 |
chr6_-_87851011 | 2.13 |
ENSMUST00000113617.1
|
Cnbp
|
cellular nucleic acid binding protein |
chrX_+_100774741 | 2.13 |
ENSMUST00000113735.2
|
Dlg3
|
discs, large homolog 3 (Drosophila) |
chr14_+_30951486 | 2.12 |
ENSMUST00000050171.8
|
Nek4
|
NIMA (never in mitosis gene a)-related expressed kinase 4 |
chr3_-_107943362 | 2.12 |
ENSMUST00000106683.1
|
Gstm6
|
glutathione S-transferase, mu 6 |
chr1_+_180851131 | 2.11 |
ENSMUST00000038091.6
|
Sde2
|
SDE2 telomere maintenance homolog (S. pombe) |
chr8_-_79294928 | 2.10 |
ENSMUST00000048718.2
|
Mmaa
|
methylmalonic aciduria (cobalamin deficiency) type A |
chr3_-_107943390 | 2.10 |
ENSMUST00000106681.1
|
Gstm6
|
glutathione S-transferase, mu 6 |
chr6_+_71493850 | 2.10 |
ENSMUST00000064637.4
ENSMUST00000114178.1 |
Rnf103
|
ring finger protein 103 |
chr13_-_119755882 | 2.08 |
ENSMUST00000178142.1
|
Nim1
|
serine/threonine-protein kinase NIM1 |
chr11_+_21239279 | 2.08 |
ENSMUST00000006221.7
ENSMUST00000109578.1 |
Vps54
|
vacuolar protein sorting 54 (yeast) |
chr15_+_75993756 | 2.08 |
ENSMUST00000089669.4
|
Mapk15
|
mitogen-activated protein kinase 15 |
chr11_-_100527862 | 2.07 |
ENSMUST00000107385.1
|
Acly
|
ATP citrate lyase |
chr19_+_18670780 | 2.06 |
ENSMUST00000025632.9
|
2410127L17Rik
|
RIKEN cDNA 2410127L17 gene |
chr8_+_46151749 | 2.05 |
ENSMUST00000154040.1
|
4933411K20Rik
|
RIKEN cDNA 4933411K20 gene |
chr7_+_107567445 | 2.05 |
ENSMUST00000120990.1
|
Olfml1
|
olfactomedin-like 1 |
chr10_-_7956223 | 2.04 |
ENSMUST00000146444.1
|
Tab2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
chr9_+_123366921 | 2.03 |
ENSMUST00000038863.7
|
Lars2
|
leucyl-tRNA synthetase, mitochondrial |
chr4_-_148159571 | 2.03 |
ENSMUST00000167160.1
ENSMUST00000151246.1 |
Fbxo44
|
F-box protein 44 |
chr2_+_163204483 | 2.03 |
ENSMUST00000128999.1
|
Tox2
|
TOX high mobility group box family member 2 |
chr2_+_104027721 | 2.03 |
ENSMUST00000028603.3
|
Fbxo3
|
F-box protein 3 |
chr12_-_24680890 | 2.03 |
ENSMUST00000156453.2
|
Cys1
|
cystin 1 |
chr4_-_62150810 | 2.02 |
ENSMUST00000077719.3
|
Mup21
|
major urinary protein 21 |
chr16_-_97922582 | 2.02 |
ENSMUST00000170757.1
|
C2cd2
|
C2 calcium-dependent domain containing 2 |
chr13_-_66933080 | 2.02 |
ENSMUST00000021991.4
|
Mterfd1
|
MTERF domain containing 1 |
chr3_+_40745332 | 2.00 |
ENSMUST00000159819.1
|
Hspa4l
|
heat shock protein 4 like |
chr18_+_24205937 | 2.00 |
ENSMUST00000164998.1
|
Galnt1
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 |
chr6_-_52640303 | 1.99 |
ENSMUST00000031788.8
|
Hibadh
|
3-hydroxyisobutyrate dehydrogenase |
chr2_+_122147680 | 1.99 |
ENSMUST00000102476.4
|
B2m
|
beta-2 microglobulin |
chr18_+_36281069 | 1.98 |
ENSMUST00000051301.3
|
Pura
|
purine rich element binding protein A |
chr2_+_18677002 | 1.98 |
ENSMUST00000028071.6
|
Bmi1
|
Bmi1 polycomb ring finger oncogene |
chr14_-_51922773 | 1.98 |
ENSMUST00000089771.2
|
Rnase13
|
ribonuclease, RNase A family, 13 (non-active) |
chr15_-_31367527 | 1.97 |
ENSMUST00000076942.4
ENSMUST00000123325.1 ENSMUST00000110410.2 |
Ankrd33b
|
ankyrin repeat domain 33B |
chr18_+_12643329 | 1.97 |
ENSMUST00000025294.7
|
Ttc39c
|
tetratricopeptide repeat domain 39C |
chr13_-_43480973 | 1.97 |
ENSMUST00000144326.2
|
Ranbp9
|
RAN binding protein 9 |
chr7_+_30553263 | 1.97 |
ENSMUST00000044048.7
|
Hspb6
|
heat shock protein, alpha-crystallin-related, B6 |
chr8_-_64733534 | 1.95 |
ENSMUST00000141021.1
|
Sc4mol
|
sterol-C4-methyl oxidase-like |
chr1_-_91413163 | 1.95 |
ENSMUST00000086851.1
|
Hes6
|
hairy and enhancer of split 6 |
chr8_-_91134027 | 1.94 |
ENSMUST00000125257.1
|
Aktip
|
thymoma viral proto-oncogene 1 interacting protein |
chr1_-_75191923 | 1.94 |
ENSMUST00000040689.8
|
Atg9a
|
autophagy related 9A |
chr4_+_148130883 | 1.94 |
ENSMUST00000084129.2
|
Mad2l2
|
MAD2 mitotic arrest deficient-like 2 |
chr1_-_57406443 | 1.92 |
ENSMUST00000160837.1
ENSMUST00000161780.1 |
Tyw5
|
tRNA-yW synthesizing protein 5 |
chrX_-_9662950 | 1.92 |
ENSMUST00000033519.2
|
Dynlt3
|
dynein light chain Tctex-type 3 |
chr3_-_107943705 | 1.92 |
ENSMUST00000106680.1
ENSMUST00000106684.1 ENSMUST00000106685.2 |
Gstm6
|
glutathione S-transferase, mu 6 |
chr17_-_56716788 | 1.91 |
ENSMUST00000067931.5
|
Vmac
|
vimentin-type intermediate filament associated coiled-coil protein |
chr2_-_33371486 | 1.91 |
ENSMUST00000113165.1
|
Ralgps1
|
Ral GEF with PH domain and SH3 binding motif 1 |
chr4_-_133339283 | 1.91 |
ENSMUST00000043305.7
|
Wdtc1
|
WD and tetratricopeptide repeats 1 |
chr7_+_65644884 | 1.91 |
ENSMUST00000032728.8
|
Tarsl2
|
threonyl-tRNA synthetase-like 2 |
chr10_+_7589788 | 1.91 |
ENSMUST00000134346.1
ENSMUST00000019931.5 |
Lrp11
|
low density lipoprotein receptor-related protein 11 |
chr4_-_133339238 | 1.90 |
ENSMUST00000105906.1
|
Wdtc1
|
WD and tetratricopeptide repeats 1 |
chr10_+_62071014 | 1.90 |
ENSMUST00000053865.5
|
Gm5424
|
predicted gene 5424 |
chr13_-_24937585 | 1.90 |
ENSMUST00000037615.6
|
Aldh5a1
|
aldhehyde dehydrogenase family 5, subfamily A1 |
chr11_+_86484647 | 1.90 |
ENSMUST00000020827.6
|
Rnft1
|
ring finger protein, transmembrane 1 |
chr16_+_90220742 | 1.89 |
ENSMUST00000023707.9
|
Sod1
|
superoxide dismutase 1, soluble |
chr11_-_100527896 | 1.89 |
ENSMUST00000107389.1
ENSMUST00000007131.9 |
Acly
|
ATP citrate lyase |
chr7_-_141193934 | 1.88 |
ENSMUST00000026572.4
ENSMUST00000168550.1 ENSMUST00000097957.4 |
Hras
|
Harvey rat sarcoma virus oncogene |
chr9_+_53301571 | 1.88 |
ENSMUST00000051014.1
|
Exph5
|
exophilin 5 |
chr7_-_34654342 | 1.88 |
ENSMUST00000108069.1
|
Kctd15
|
potassium channel tetramerisation domain containing 15 |
chr19_-_29805989 | 1.88 |
ENSMUST00000177155.1
ENSMUST00000059484.7 |
9930021J03Rik
|
RIKEN cDNA 9930021J03 gene |
chr8_+_127064107 | 1.88 |
ENSMUST00000162536.1
ENSMUST00000026921.6 ENSMUST00000162665.1 ENSMUST00000160766.1 ENSMUST00000162602.1 ENSMUST00000162531.1 ENSMUST00000160581.1 ENSMUST00000161355.1 ENSMUST00000159537.1 |
Pard3
|
par-3 (partitioning defective 3) homolog (C. elegans) |
chr3_+_40745430 | 1.87 |
ENSMUST00000077083.6
|
Hspa4l
|
heat shock protein 4 like |
chr1_+_78657825 | 1.86 |
ENSMUST00000035779.8
|
Acsl3
|
acyl-CoA synthetase long-chain family member 3 |
chr11_-_105944412 | 1.85 |
ENSMUST00000019734.4
ENSMUST00000184269.1 ENSMUST00000150563.1 |
Cyb561
|
cytochrome b-561 |
chr7_-_133776681 | 1.85 |
ENSMUST00000130182.1
ENSMUST00000106139.1 |
Dhx32
|
DEAH (Asp-Glu-Ala-His) box polypeptide 32 |
chr11_-_113708952 | 1.85 |
ENSMUST00000106617.1
|
Cpsf4l
|
cleavage and polyadenylation specific factor 4-like |
chr5_-_138994935 | 1.84 |
ENSMUST00000046901.7
ENSMUST00000076095.7 |
Pdgfa
|
platelet derived growth factor, alpha |
chr9_-_54560138 | 1.84 |
ENSMUST00000041901.6
|
Cib2
|
calcium and integrin binding family member 2 |
chr16_+_64851991 | 1.83 |
ENSMUST00000067744.7
|
Cggbp1
|
CGG triplet repeat binding protein 1 |
chr5_+_30921556 | 1.83 |
ENSMUST00000031053.8
|
Khk
|
ketohexokinase |
chr19_-_4042165 | 1.83 |
ENSMUST00000042700.9
|
Gstp2
|
glutathione S-transferase, pi 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 18.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
1.8 | 5.5 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
1.6 | 4.8 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
1.4 | 14.5 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.4 | 7.0 | GO:0032902 | nerve growth factor production(GO:0032902) |
1.4 | 6.9 | GO:0070178 | D-serine metabolic process(GO:0070178) |
1.2 | 3.7 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
1.2 | 3.7 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
1.2 | 1.2 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
1.2 | 4.8 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
1.2 | 4.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
1.1 | 1.1 | GO:1902728 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
1.1 | 3.2 | GO:0006562 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
1.0 | 9.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.0 | 3.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
1.0 | 4.1 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
1.0 | 3.1 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
1.0 | 6.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.0 | 3.1 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
1.0 | 3.0 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.0 | 4.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.0 | 2.0 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
1.0 | 2.9 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
1.0 | 2.9 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
1.0 | 2.9 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.9 | 1.9 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.9 | 2.8 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.9 | 0.9 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.9 | 3.7 | GO:0061625 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.9 | 4.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.9 | 2.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.9 | 2.6 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.9 | 3.4 | GO:1904412 | regulation of cardiac ventricle development(GO:1904412) |
0.9 | 2.6 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.9 | 3.4 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.8 | 0.8 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.8 | 1.7 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
0.8 | 2.5 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.8 | 5.0 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.8 | 8.2 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.8 | 2.5 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.8 | 2.4 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.8 | 2.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.8 | 5.5 | GO:0070054 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
0.8 | 3.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.8 | 8.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.8 | 2.3 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.7 | 0.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.7 | 2.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.7 | 2.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.7 | 0.7 | GO:0042196 | chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.7 | 5.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.7 | 3.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.7 | 0.7 | GO:0035973 | aggrephagy(GO:0035973) |
0.7 | 2.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.7 | 2.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.7 | 3.5 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.7 | 3.4 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.7 | 2.7 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.7 | 2.0 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.7 | 2.7 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.7 | 0.7 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.7 | 2.0 | GO:1901355 | response to rapamycin(GO:1901355) |
0.7 | 1.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.7 | 2.0 | GO:0097065 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.7 | 2.0 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.7 | 4.6 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.6 | 2.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.6 | 2.6 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.6 | 0.6 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.6 | 2.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.6 | 3.2 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.6 | 1.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.6 | 5.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.6 | 3.8 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.6 | 6.3 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.6 | 0.6 | GO:1904173 | regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
0.6 | 1.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.6 | 1.8 | GO:0060466 | activation of meiosis involved in egg activation(GO:0060466) |
0.6 | 5.5 | GO:0046449 | creatinine metabolic process(GO:0046449) |
0.6 | 1.8 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.6 | 1.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.6 | 6.7 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.6 | 2.4 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 1.8 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.6 | 1.2 | GO:0090427 | activation of meiosis(GO:0090427) |
0.6 | 3.6 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.6 | 3.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.6 | 1.8 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
0.6 | 0.6 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.6 | 1.1 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.6 | 3.3 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
0.6 | 3.3 | GO:0001757 | somite specification(GO:0001757) |
0.5 | 3.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.5 | 1.6 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.5 | 1.6 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.5 | 2.2 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.5 | 2.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.5 | 3.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.5 | 2.1 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.5 | 2.1 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.5 | 1.5 | GO:0009073 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
0.5 | 1.5 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.5 | 0.5 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.5 | 1.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 1.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.5 | 0.5 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.5 | 4.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 1.5 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
0.5 | 2.5 | GO:0009414 | response to water deprivation(GO:0009414) |
0.5 | 1.0 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) |
0.5 | 2.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.5 | 1.5 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.5 | 1.9 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.5 | 2.9 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.5 | 2.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.5 | 1.9 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.5 | 1.4 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.5 | 2.8 | GO:0003383 | apical constriction(GO:0003383) |
0.5 | 3.8 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.5 | 3.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 5.6 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.5 | 1.4 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.5 | 1.4 | GO:1903002 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
0.5 | 3.2 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.5 | 1.4 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.5 | 0.5 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.5 | 3.2 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.5 | 2.3 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 1.3 | GO:0046370 | fructose biosynthetic process(GO:0046370) |
0.4 | 0.9 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.4 | 1.8 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.4 | 2.2 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.4 | 2.7 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.4 | 1.3 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.4 | 5.3 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.4 | 0.4 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
0.4 | 1.3 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
0.4 | 1.3 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.4 | 0.4 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.4 | 1.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.4 | 1.3 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.4 | 1.7 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.4 | 3.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 1.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 5.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 1.7 | GO:0034031 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
0.4 | 0.8 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.4 | 3.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.4 | 1.7 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
0.4 | 7.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.4 | 1.2 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
0.4 | 2.0 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 1.2 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.4 | 1.6 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 1.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.4 | 0.8 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.4 | 0.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.4 | 1.6 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.4 | 1.2 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
0.4 | 2.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 1.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 1.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.4 | 1.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.4 | 14.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.4 | 2.4 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.4 | 1.2 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.4 | 1.2 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.4 | 1.9 | GO:0044805 | late nucleophagy(GO:0044805) |
0.4 | 5.8 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.4 | 8.2 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.4 | 2.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 1.5 | GO:0036482 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
0.4 | 3.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 0.4 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.4 | 6.9 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.4 | 1.5 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.4 | 2.3 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.4 | 1.9 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.4 | 2.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 1.1 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.4 | 3.8 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.4 | 1.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.4 | 1.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 2.2 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.4 | 1.1 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.4 | 2.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 2.6 | GO:0001302 | replicative cell aging(GO:0001302) |
0.4 | 1.9 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.4 | 2.6 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.4 | 1.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.4 | 2.9 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.4 | 1.5 | GO:0003360 | brainstem development(GO:0003360) |
0.4 | 3.6 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.4 | 4.7 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.4 | 2.5 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.4 | 1.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.4 | 2.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.4 | 0.7 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.4 | 1.8 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.4 | 2.5 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.4 | 1.4 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.4 | 0.7 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.4 | 3.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.4 | 1.1 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.4 | 2.5 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
0.4 | 5.6 | GO:0010225 | response to UV-C(GO:0010225) |
0.4 | 0.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.4 | 1.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 0.7 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
0.3 | 0.3 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.3 | 1.4 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.3 | 0.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 2.4 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 1.4 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.3 | 1.0 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.3 | 1.0 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.3 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.3 | 1.0 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.3 | 2.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 1.7 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.3 | 1.4 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.3 | 1.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.3 | 1.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 2.0 | GO:1900145 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
0.3 | 2.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.3 | 2.0 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.3 | 2.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.3 | 1.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.3 | 1.3 | GO:0016240 | autophagosome docking(GO:0016240) |
0.3 | 1.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.3 | 0.3 | GO:0007172 | signal complex assembly(GO:0007172) |
0.3 | 0.6 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.3 | 1.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.3 | 0.6 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 3.9 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.3 | 1.3 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.3 | 1.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.3 | 1.0 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.3 | 1.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.3 | 1.0 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.3 | 0.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.3 | 1.3 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.3 | 0.9 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.3 | 1.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.9 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 0.9 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.3 | 9.0 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.3 | 0.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 1.2 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.3 | 1.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 0.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.3 | 1.2 | GO:2000292 | regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
0.3 | 1.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 1.2 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.3 | 1.5 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.3 | 2.8 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.3 | 12.8 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 4.6 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.3 | 0.3 | GO:0060701 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.3 | 0.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 1.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.3 | 2.1 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 0.9 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.3 | 1.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 1.2 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.3 | 2.7 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 2.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 0.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 4.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.3 | 1.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.3 | 1.2 | GO:1901582 | post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
0.3 | 3.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 3.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.3 | 0.6 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.3 | 0.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 0.9 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.3 | 2.0 | GO:0015862 | uridine transport(GO:0015862) |
0.3 | 0.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.3 | 2.6 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.3 | 2.6 | GO:0009301 | snRNA transcription(GO:0009301) |
0.3 | 1.1 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.3 | 1.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.3 | 2.5 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 0.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.3 | 1.4 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.3 | 2.8 | GO:0046959 | habituation(GO:0046959) |
0.3 | 1.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 0.6 | GO:1990401 | embryonic lung development(GO:1990401) |
0.3 | 1.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 0.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.3 | 1.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 0.3 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.3 | 0.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 2.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.3 | 1.9 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 0.8 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
0.3 | 1.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.3 | 0.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.3 | 3.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 0.3 | GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process(GO:0032805) |
0.3 | 0.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 1.3 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.3 | 1.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.3 | 0.8 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.3 | 4.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 1.1 | GO:0035553 | oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 1.1 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.3 | 1.6 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.3 | 9.0 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.3 | 3.4 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.3 | 1.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 3.4 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.3 | 1.3 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.3 | 0.5 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
0.3 | 0.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.3 | 0.8 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 1.3 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.3 | 6.8 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.3 | 1.0 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.3 | 0.8 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.3 | 1.0 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 0.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 2.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 1.3 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.3 | 1.8 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.3 | 0.8 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.3 | 0.8 | GO:0021759 | globus pallidus development(GO:0021759) |
0.3 | 0.8 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.3 | 2.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.3 | 2.8 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.3 | 1.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 2.3 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.3 | 2.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 1.0 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.3 | 1.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.3 | 0.3 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.2 | 1.0 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
0.2 | 1.0 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.2 | 0.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 0.7 | GO:1903286 | regulation of potassium ion import(GO:1903286) |
0.2 | 2.0 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.2 | 1.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 2.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 2.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 2.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 0.7 | GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
0.2 | 1.5 | GO:0015679 | plasma membrane copper ion transport(GO:0015679) copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
0.2 | 3.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.2 | 0.2 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.2 | 0.2 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.2 | 0.2 | GO:0046619 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
0.2 | 1.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 1.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 0.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 1.0 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.7 | GO:0061075 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.2 | 2.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 0.2 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.2 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.7 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 3.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.2 | 1.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 0.7 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.2 | 0.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.7 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 5.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.2 | 0.2 | GO:0002465 | peripheral T cell tolerance induction(GO:0002458) peripheral tolerance induction(GO:0002465) |
0.2 | 0.5 | GO:0006507 | GPI anchor release(GO:0006507) |
0.2 | 0.2 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.2 | 0.9 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.2 | 3.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 1.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 0.7 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.2 | 0.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 1.8 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 9.6 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.9 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 2.5 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 0.7 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.2 | 0.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 0.7 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.2 | 0.2 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 9.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.7 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.2 | 1.1 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 0.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.9 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
0.2 | 0.7 | GO:0061193 | taste bud development(GO:0061193) |
0.2 | 0.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.2 | 1.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.7 | GO:1904811 | dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
0.2 | 0.7 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.2 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.2 | 0.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 1.9 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 5.4 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 0.2 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.2 | 2.8 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.2 | 0.6 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.2 | 0.9 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.2 | 0.9 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.2 | 1.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 0.6 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.2 | 0.4 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 1.5 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.2 | 0.4 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.2 | 0.2 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.2 | 0.4 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.2 | 1.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 1.0 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.6 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 1.0 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) tyrosine catabolic process(GO:0006572) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.2 | 9.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.6 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
0.2 | 0.8 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 3.1 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 1.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 1.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 1.6 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 1.8 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 0.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 1.0 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 0.4 | GO:0002188 | translation reinitiation(GO:0002188) |
0.2 | 0.4 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 0.6 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 0.6 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.2 | 3.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 1.4 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 2.5 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.8 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 0.4 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.2 | 1.0 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.2 | 0.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 1.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 1.4 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.4 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.2 | 1.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 0.6 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 1.0 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 1.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 7.2 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.2 | 2.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 0.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 0.6 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.2 | 1.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 0.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 1.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.6 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 0.9 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.2 | 0.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.7 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.2 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.2 | 1.7 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 1.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 1.3 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.2 | 6.1 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.2 | 1.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.6 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 0.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.2 | 1.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 0.4 | GO:1903294 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.2 | 0.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.2 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.2 | 0.5 | GO:0046032 | ADP catabolic process(GO:0046032) |
0.2 | 1.6 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 1.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 11.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.5 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.2 | 2.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.7 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.2 | 1.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 1.6 | GO:0060717 | chorion development(GO:0060717) |
0.2 | 1.1 | GO:0097502 | mannosylation(GO:0097502) |
0.2 | 0.2 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
0.2 | 0.4 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.2 | 2.7 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 1.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 1.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 2.3 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 1.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 1.8 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 1.0 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.2 | 0.3 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.2 | 1.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 0.5 | GO:2000836 | positive regulation of androgen secretion(GO:2000836) positive regulation of testosterone secretion(GO:2000845) |
0.2 | 1.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.9 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.2 | 0.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 1.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 8.8 | GO:0022900 | electron transport chain(GO:0022900) |
0.2 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.3 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.2 | 0.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 0.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 0.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 1.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.5 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 1.2 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.2 | 1.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 1.0 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.2 | 1.5 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 0.5 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.2 | 0.5 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.2 | 0.3 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.2 | 2.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 1.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 2.8 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.2 | GO:1904109 | positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
0.2 | 2.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 2.8 | GO:0000338 |